Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01307449 · ClinicalTrials.gov registry record · NA
Systems Biology of PNEUMOVAX®23 and PREVNAR 13®
A NA study of Pneumococcal Infection, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 2
- Study locations
NCT01307449 is a NA study of Pneumococcal Infection that has completed, run by Emory University. The registered enrollment target is 88 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT01307449, a NA study of Pneumococcal Infection, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 2
- Study locations
Study Summary
Vaccination is the most effective way of preventing infectious diseases. Despite the success of vaccines in general, vaccines induce diminished antibody responses and lower protection in the elderly in particular. This could be explained by a defect in the early responses of an ageing immune system. A better understanding of the basic immunological mechanisms that mediate vaccine efficacy is incomplete. Such information is critical and could greatly decrease both the cost and the time to new vaccine development particularly for the geriatric population. In this trial, the investigators will study the immunologic differences of two FDA approved licensed pneumococcal vaccines between a younger and an older group. Twenty two healthy volunteers between the age of 25-40 and sixty six healthy volunteers between the ages of 60-89 will be enrolled in the study. Each participant in the study will be given one pneumococcal shot. Blood work will be obtained prior to vaccination, one day, three days, seven days, fourteen days, as well as one month and six months after vaccination. Throughout the duration of the study, the participants will be monitored for safety.
Conditions Studied
Interventions
- BIOLOGICAL PNEUMOVAX
- BIOLOGICAL Prevnar
Study Locations (2)
Georgia
- Hope Clinic of the Emory Vaccine Center - Decatur
- Atlanta VA Medical Center - Decatur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2014-04 |
| Est. Completion | 2017-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01307449
The ClinicalTrials.gov registry entry for NCT01307449 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pneumococcal Infection appearing as the primary indexed condition, and to 2 interventions - of which PNEUMOVAX is the first listed.
NCT01307449 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT01307449 about?
NCT01307449 is a clinical study titled "Systems Biology of PNEUMOVAX®23 and PREVNAR 13®". Vaccination is the most effective way of preventing infectious diseases. Despite the success of vaccines in general, vaccines induce diminished antibody responses and lower protection in the elderly in particular. This could be explained by a defect in the early responses of an ageing immune system....
What is the current status of trial NCT01307449?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2014-04. Estimated completion is 2017-07.
What conditions does trial NCT01307449 study?
This clinical trial studies the following conditions: Pneumococcal Infection.
What interventions are being tested in trial NCT01307449?
The interventions under investigation include: PNEUMOVAX (BIOLOGICAL), Prevnar (BIOLOGICAL).
Who is sponsoring clinical trial NCT01307449?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01307449 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumococcal Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.